TG 101348 - Fedratinib | SAR 302503

Based on 265 publications in PubMed 10 10 265

Axon 1588

CAS [936091-26-8]

MF C27H36N6O3S
MW 524.68

  • Purity: 99%
  • Soluble in DMSO

TG 101348

Description

An orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 (JAK2, IC50: ca 3 nM) with potential antineoplastic activity.

KEYWORDS: TG 101348 | supplier | JAK2 inhibitor | Fedratinib | SAR 302503 | TG101348 | SAR302503 | TG-101348 | SAR-302503 | CAS [936091-26-8] | JAK-STAT Pathway | Janus-associated kinase | antineoplastic | hematopoietic stem cell | HSC

Order
Size Unit Price Stock
5 mg €95.00 In Stock
25 mg €285.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €140.00 In Stock
2 x 25 mg €440.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...